CURE staff

Watch Dr. Anne O'Dea, from University of Kansas Medical Center, discuss targeting ESR1 mutations during the CURE Educated Patient® Breast Cancer Summit at MBCC.

As part of its Heal at Home series, CURE® worked with a registered dietitian from Georgetown Lombardi Comprehensive Cancer Center to put together several cancer-friendly dishes that everyone can enjoy this summer.

The vaccine immune response monitoring platform can identify weak responses in patients with cancer and help determine the potential need for a booster shot.

Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.

View the full CURE Educated Patient Breast Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

CURE will host a webinar, sponsored by Amgen, in which panelists from several cancer organizations will discuss ways to improve awareness around biomarker testing, improve coordination of care for patients with lung cancer and remove barriers to access to care.

CURE® is proud present the EDUCATED PATIENT® Gastrointestinal Stromal Tumor (GIST) Webinar from Tuesday, January 26, 2021.

A roundup of some skin cancer news and updates that occurred in 2020 that patients may have missed.

A roundup of some kidney cancer news and updates that occurred in 2020 that patients may have missed.

A roundup of some ovarian cancer news and updates that occurred in 2020 that patients may have missed.

Here are the top 10 most popular contributor articles from 2020!

A roundup of some of the most read news and updates in breast cancer in 2020 from CURE®.

A roundup of some of the most read news and updates in follicular lymphoma in 2020 from CURE®.

A roundup of some of the most read news and updates in mantle cell lymphoma in 2020 from CURE®.

A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.

The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.

The decision was based on data that demonstrated sotorasib induced anticancer activity and achieved a positive benefit-risk profile in patients with locally advanced or metastatic non-small cell lung cancer whose disease harbors a KRAS G12C mutation.

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Santure was recognized for her compassionate care for patients and their families; also during virtual ceremony, Elizabeth Farrat named 2020 The Finest Hour award winner.

Charles J. Ryan, M.D., internationally recognized for his research on prostate cancer, discusses risk factors, treatments and racial disparities associated with the disease.

A roundup of the latest news and updates for patients with metastatic breast cancer from CURE®.

A roundup of the latest news and updates for patients with prostate cancer from CURE®.

Join us for our Chronic Lymphocytic Leukemia webinar where experts discuss CLL information highly relevant to patients, caregivers, advocates and discuss patient questions.

On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.

On social media, CURE® recently asked its readers to share how they pamper and treat themselves during or after their cancer treatment. Here, we share some of their responses.

On social media, CURE® recently asked its readers to share how they cope with anxiety leading up to their next scans. Here, we share some of their responses.

The FDA’s fast track designation for BST-236 to treat adults aged 75 years or older with acute myeloid leukemia, or who have comorbidities that prevent the use of intensive induction chemotherapy, may open the doors to an accelerated approval.

On social media, CURE® recently asked its readers to share the advice they would give someone looking to help a friend or loved one with cancer. Here, we share some of their responses.

A roundup of the latest news and updates for patients with ovarian cancer from CURE®.